The Role of Centaurin-α1 in Alzheimer’s Disease Pathology

Principal Investigator
Ryohei Yasuda, PhD
Max Planck Florida Institute for Neuroscience
Jupiter, FL, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$250,000
Active Dates
July 01, 2015 - June 30, 2018
Grant ID
A2015251S
Summary
It is thought that Alzheimer’s disease is caused by accumulation of ß-Amyloid. We recently identified that a signaling protein called centaurin-a1 (CentA1) causes ß-Amyloid-induced dysfunction of neurons and thus potentially contributes to brain dysfunction in Alzheimer’s disease. In this project, we will further study the potential roles of CentA1 in Alzheimer’s disease using newly developed CentA1 knockout mice in combination with the model mice for Alzheimer’s disease. We hope that this will lead to new therapeutics targeting CentA1.
Related Grants
Alzheimer's Disease Research
Neurostimulation to Improve Depression and Memory in Dementia
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Davide Cappon, PhD
Current Organization
Hebrew Rehabilitation Center
Neurostimulation to Improve Depression and Memory in Dementia
Active Dates
July 01, 2024 - June 30, 2027

Principal Investigator
Davide Cappon, PhD
Current Organization
Hebrew Rehabilitation Center
Alzheimer's Disease Research
Unfolding Alzheimer's Tau Therapies: Near- and Long-Term Approaches
Active Dates
July 01, 2023 - June 30, 2026
Principal Investigator
Paul Seidler, PhD
Current Organization
University of Southern California
Unfolding Alzheimer's Tau Therapies: Near- and Long-Term Approaches
Active Dates
July 01, 2023 - June 30, 2026

Principal Investigator
Paul Seidler, PhD
Current Organization
University of Southern California
Alzheimer's Disease Research
Modeling MRI Brain Aging in Autosomal Dominant Alzheimer's Disease
Active Dates
July 01, 2022 - June 30, 2025
Principal Investigator
Peter Millar, PhD
Current Organization
Washington University School of Medicine in St. Louis
Modeling MRI Brain Aging in Autosomal Dominant Alzheimer's Disease
Active Dates
July 01, 2022 - June 30, 2025

Principal Investigator
Peter Millar, PhD
Current Organization
Washington University School of Medicine in St. Louis